Based on the Galderma Group N stock forecast from 0 analysts, the average analyst target price for Galderma Group N is not available over the next 12 months. Galderma Group N’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Galderma Group N is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Galderma Group N’s stock price was CHF 113.74. Galderma Group N’s stock price has changed by +0.60% over the past week, +4.12% over the past month and 0% over the last year.
No recent analyst target price found for Galderma Group N
No recent average analyst rating found for Galderma Group N
Company Overview Galderma Group N
N/A
N/A
N/A
N/A
CHF
Switzerland
Adjusted Closing Price for Galderma Group N (GALD:VX)
Loading...
Unadjusted Closing Price for Galderma Group N (GALD:VX)
Loading...
Share Trading Volume for Galderma Group N Shares
Loading...
Compare Performance of Galderma Group N Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for GALD:VX
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Galderma Group N (Sector: Others )
N/A
Frequently Asked Questions About Galderma Group N (GALD:VX) Stock
Stock Target Advisor's fundamental analysis for Galderma Group N's stock is Neutral.
Unfortunately we do not have enough data on GALD:VX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on GALD:VX's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on GALD:VX's stock to indicate if its overvalued.
The last closing price of GALD:VX's stock was CHF 113.74.
Unfortunately we do not currently have any market capitalization data for GALD:VX's stock.
Unfortunately we do not have enough analyst data on GALD:VX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Galderma Group N's stock.
Sorry, we do not have any data on the number of employees for Galderma Group N.
Sorry we do not have any infomation available on Galderma Group N's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Frequently Asked Questions About Galderma Group N (GALD:VX) Stock
Stock Target Advisor's fundamental analysis for Galderma Group N's stock is Neutral.
Unfortunately we do not have enough data on GALD:VX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on GALD:VX's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on GALD:VX's stock to indicate if its overvalued.
The last closing price of GALD:VX's stock was CHF 113.74.
Unfortunately we do not currently have any market capitalization data for GALD:VX's stock.
Unfortunately we do not have enough analyst data on GALD:VX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Galderma Group N's stock.
Sorry, we do not have any data on the number of employees for Galderma Group N.
Sorry we do not have any infomation available on Galderma Group N's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GALD:VX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
